Evaluating the use of baclofen as adjunct treatment for muscle tension dysphonia

Author(s):  
Madhav Sambhu ◽  
Ted Goh ◽  
Hadas Golan ◽  
Jessica Pisegna ◽  
Jacob Pieter Noordzij
2020 ◽  
Vol 130 (4) ◽  
pp. 980-985 ◽  
Author(s):  
Daniel Novakovic ◽  
Duong Duy Nguyen ◽  
Antonia Chacon ◽  
Catherine Madill

2015 ◽  
Vol 25 (1) ◽  
pp. 5-15 ◽  
Author(s):  
Martin L. Spencer

This article will briefly identify the variable nature of muscle tension dysphonia (MTD). Causes such as psychogenicity and maladaptive “vocal posture” will be described and questioned. Special Interest Group (SIG) 3 members may benefit from identification of the strengths and weaknesses of an ongoing movement towards a symptomatically generic “MTD.” More specific subtyping of MTD into 9 categories will be proposed, as well as description of associated therapy methods. Increased patient awareness that some subtypes may be self-correctable could simplify intervention, increase compliance, and improve clinician and researcher effectiveness.


2016 ◽  
Vol 4 (3) ◽  
pp. 175-182 ◽  
Author(s):  
Melda Kunduk ◽  
Daniel S. Fink ◽  
Andrew J. McWhorter

2020 ◽  
Vol 34 (3) ◽  
pp. 488.e9-488.e27 ◽  
Author(s):  
Narges Jafari ◽  
Abolfazl Salehi ◽  
Iris Meerschman ◽  
Farzad Izadi ◽  
Abbas Ebadi ◽  
...  

Author(s):  
You Young An ◽  
Jun Yeong Jeong ◽  
Ki Nam Park ◽  
Seung Won Lee

Muscle tension dysphonia (MTD) is a voice disorder characterized by excessive tension of the laryngeal muscles during phonation. Voice therapy is the gold standard of treatment for MTD. However, patients with MTD do not always respond to voice therapy. Multidisciplinary approaches have been attempted to treat intractable MTD such as lidocaine instillation, lidocaine injection to recurrent laryngeal nerve, botox injection and excision of false ventricle using CO2 laser. Recently, injection laryngoplasty is suggested that assists in more efficient phonation and voice therapy to MTD patients. A patient with intractable MTD underwent lidocaine injection and injection laryngoplasty showed improved voice quality and remained stable until postoperative 3 months without any complications.


2021 ◽  
Author(s):  
Elizabeth Erickson-DiRenzo ◽  
Christine M. Kim ◽  
C. Kwang Sung Sung

Presbylarynx refers to age-related structural changes of the vocal folds that include muscle atrophy, reduced neuromuscular control, loss of superficial lamina propria layer, and reduced pliability. The changes result in thin and bowed vocal folds, increased vocal effort requirements, breathy voice, change in habitual pitch, and strain. The primary treatment options are voice therapy focused on strengthening breath support and the intrinsic muscles of the larynx, and optimization of resonance; injection augmentation of the vocal folds; and type I thyroplasty. Functional dysphonia is defined as change in voice quality in the absence of structural or neurological abnormalities of the larynx. Muscle tension dysphonia (MTD) is a subtype of functional voice disorders and involves laryngeal muscle tension imbalance due to excessive or dysregulated activation resulting often in strained or breathy voice. MTD can be divided into primary (psychological etiology or vocal misuse) and secondary (compensatory for organic laryngeal pathology). The mainstay of treatment for MTD is voice therapy, along with medical or surgical treatment of the underlying vocal pathology in secondary MTD. Mutational falsetto, or puberphonia, is a functional voice disorder where a high-pitched, pre-adolescent voice fails to transition to the lower pitch of adulthood. This review contains 5 figures, 7 tables, 4 videos and 10 references Key Words: Presbylarynx, Injection augmentation, Type I thyroplasty, Primary muscle tension dysphonia, Secondary muscle tension dysphonia, Muscle tension patterns, Manual circumlaryngeal therapy, Functional dysphonia, Mutational falsetto  


Sign in / Sign up

Export Citation Format

Share Document